Меню
Идёт набор NCT04856501

A Randomized Control Trial of a Responsive Parenting Intervention to Support Healthy Brain Development and Self-regulation in Toddlers Born Preterm

Без фазы С лечением Premature Birth

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: PALS intervention condition, Control condition.
Кому может быть актуально
Состояния в реестре: Premature Birth. Базовые параметры: 15 мес. — 30 мес. · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

The purpose of this study is to determine whether participation in the Play and Learning Strategies (PALS) parenting intervention results in increased caregiver responsiveness behaviors and to test if participation in PALS results in increases in toddler skills and/or toddler neurological development.

Вмешательства

  • Поведенческое PALS intervention condition
    The Play and Learning Strategies (PALS) intervention provides parents with behaviors that, collectively, are known as a responsive parenting style. Four constructs make up this responsive parenting style: 1) contingent responsiveness, (responses are conditionally linked to the child's signals) 2) warm sensitivity (high levels of affection and understanding of child states), 3) maintaining vs. redirecting attention, and 4) verbal scaffolding (providing child appropriate language supports). Parent
  • Поведенческое Control condition
    Families assigned to the control condition will be provided with a website with information corresponding to milestones of toddler development. Control families will be asked to review that week's materials before the each of the 9 weekly coach calls. The active control condition serves three important purposes: 1) Maintains an active line of communication and accurate contact records for Post-test 1 and Post-test 2 session scheduling; 2) Masks participant's awareness of intervention vs. control

Первичные конечные точки

  • Change in Parental contingent responsiveness as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Parental warm sensitivity (display of positive affect) as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Parental warm sensitivity (warmth) as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Parental maintaining of child's signals and interests as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Parental verbal scaffolding as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Child attentional engagement (engagement with environment) as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Child attentional engagement (social engagement) as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Child emotional regulation as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Child cooperation as measured by the Parent-child Toy Play Observation [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
  • Change in Child emotional regulation (proximity seeking behaviors) as assessed by score on Waiting Task [Срок оценки: Baseline, Post-test 1 (1-2 weeks after intervention)]
Вторичные конечные точки (4)
  • Maternal depression as measured by the Beck's Depression Inventory [Срок оценки: Post-test 1 (1-2 weeks post intervention)]
  • Degree of chaos in the home as measured by the CHAOS questionnaire [Срок оценки: Post-test 1 (1-2 weeks post intervention)]
  • COVID-19 Exposure and Family Impact as assessed by the COVID-19 Exposure and Family Impact Survey - Exposure Score [Срок оценки: Post-test 1 (1-2 weeks post intervention)]
  • COVID-19 Exposure and Family Impact as assessed by the COVID-19 Exposure and Family Impact Survey - Impact Score [Срок оценки: Post-test 1 (1-2 weeks post intervention)]

Критерии участия

Критерии включения

\- Maternal age over 18-years when child was born

Критерии исключения

  • presence of known/suspected congenital anomalies including chromosomal or complex congenital heart disease
  • congenital infection including TORCH (Toxoplasmosis, Rubella, Cytomegalovirus, Herpes Simplex and others),untreated maternal HIV, or maternal syphilis
  • bilateral grade 3/4 intraventricular hemorrhage,intraparenchymal hemorrhage, hydrocephalus
  • Cerebral palsy with Gross Motor Function Classification of III or higher
  • blindness-
  • deafness
  • Current maternal drug use or maternal drug use during pregnancy
  • families who reside outside the catchment area (>1 hour drive from the Texas Medical Center)
  • Child with contraindication for MRI. If the mother of the child is pregnant, thinks she might be pregnant, or has a contraindication for MRI, another relative of the child will be asked to assist with the MRIs

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Профилактика

Центры проведения

США · 1 центр
  • The University of Texas Health Science Center at Houston — Houston

Идентификаторы

NCT: NCT04856501 · HSC-MS-17-0190 · 1R01HD100560-01A1

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗